Agenus, Inc. (AGEN)
8.24
+0.15
(+1.85%)
USD |
NASDAQ |
Sep 03, 16:00
8.07
-0.17
(-2.06%)
After-Hours: 07:11
Agenus Cash from Investing (Quarterly) : 0.267M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.267M |
| March 31, 2026 | 68.95M |
| December 31, 2025 | 0.78M |
| September 30, 2025 | 0.076M |
| June 30, 2025 | 0.281M |
| March 31, 2025 | 0.057M |
| December 31, 2024 | -0.021M |
| September 30, 2024 | 0.056M |
| June 30, 2024 | -0.237M |
| March 31, 2024 | 0.229M |
| December 31, 2023 | 2.824M |
| September 30, 2023 | 11.55M |
| June 30, 2023 | 0.517M |
| March 31, 2023 | -11.49M |
| December 31, 2022 | -6.383M |
| September 30, 2022 | -15.64M |
| June 30, 2022 | -4.058M |
| March 31, 2022 | -7.533M |
| December 31, 2021 | -13.30M |
| September 30, 2021 | -27.38M |
| June 30, 2021 | -2.27M |
| March 31, 2021 | -0.196M |
| December 31, 2020 | -0.834M |
| September 30, 2020 | -0.873M |
| June 30, 2020 | -2.09M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.644M |
| December 31, 2019 | -1.056M |
| September 30, 2019 | -0.839M |
| June 30, 2019 | -1.261M |
| March 31, 2019 | -1.501M |
| December 31, 2018 | -0.6015M |
| September 30, 2018 | -0.819M |
| June 30, 2018 | -0.6807M |
| March 31, 2018 | -1.490M |
| December 31, 2017 | 4.246M |
| September 30, 2017 | 9.040M |
| June 30, 2017 | -5.960M |
| March 31, 2017 | -5.262M |
| December 31, 2016 | 10.67M |
| September 30, 2016 | 24.98M |
| June 30, 2016 | 18.40M |
| March 31, 2016 | -36.46M |
| December 31, 2015 | -27.94M |
| September 30, 2015 | -1.304M |
| June 30, 2015 | -16.20M |
| March 31, 2015 | 14.21M |
| December 31, 2014 | -1.704M |
| September 30, 2014 | -0.3086M |
| June 30, 2014 | -15.14M |
| March 31, 2014 | 0.3419M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Novavax, Inc. | 34.90M |
| Amgen, Inc. | -569.00M |
| Anika Therapeutics, Inc. | -1.28M |
| BioCryst Pharmaceuticals, Inc. | -110.15M |
| Imunon, Inc. | -0.0691M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -31.20M |
| Cash from Financing (Quarterly) | 14.68M |
| Free Cash Flow | -98.50M |
| Free Cash Flow Per Share (Quarterly) | -0.7547 |
| Free Cash Flow to Equity (Quarterly) | -16.91M |
| Free Cash Flow to Firm (Quarterly) | -15.84M |
| Free Cash Flow Yield | -32.35% |